Foley & Lardner LLP Director of Diversity, Equity, & Inclusion Alexis Robertson is quoted in the Bloomberg Law article, “Women, Minority Law Firm Gains Dampened by Litigation Threat,” offering insight on how the continued growth in representation for women and minorities in the legal industry is being impacted by litigation.
Law firms and other private employers are waiting to see how the latest anti-DEI workplace sentiments impact their talent pipeline and overall diversity, equity and inclusion efforts, explained Robertson.
“We are in a moment of a chilling effect,” Robertson said. “Firms are unsure what they can or can’t still do to make progress on their DEI efforts.”
People
![](https://www.foley.com/wp-content/uploads/2023/11/Robertson_Alexis_09748-416x416.jpg)
Alexis P. Robertson
Director of Diversity, Equity, & Inclusion
[email protected]
Chicago
312.832.4715
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”